Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group - Lin, N U; Wefel, J S; Lee, E Q (Lancet Oncol, 2013)
, et al; Response Assessment in Neuro-Oncology (RANO) group.